Ms Linh Mai
Higher Degree by Research Candidate
School of Medicine
College of Health
I completed my PhD in Medicine at the University of Adelaide, based in the School of Medicine and the Centre for Translational Pathway Research. My research focused on the tumour microbiome in head and neck cancer, particularly how tumour-associated bacteria influence microbial adaptation, cancer biology, and treatment response.
My doctoral work investigated head and neck cancer-associated Streptococcus using bacterial genomics, microbiology, cancer cell biology, and transcriptomic analysis. Through this work, I examined how these bacteria adapt to the tumour microenvironment, respond to chemotherapy, and modulate cancer cell responses to treatment.
More broadly, my research interests include cancer biology, tumour microbiology, host–microbe interactions, chemotherapy resistance, multi-omics analysis, and translational cancer research. My work combines wet-lab experimentation and computational biology, with the long-term goal of translating microbiome research into clinically relevant strategies for cancer care.
| Date | Position | Institution name |
|---|---|---|
| 2022 - ongoing | Higher Research Candidate | University of Adelaide |
| Language | Competency |
|---|---|
| Chinese (Mandarin) | Can speak and understand spoken |
| English | Can read, write, speak, understand spoken and peer review |
| Vietnamese | Can read, write, speak, understand spoken and peer review |
| Date | Institution name | Country | Title |
|---|---|---|---|
| 2022 | University of Adelaide | Australia | PhD |
| 2020 - 2021 | University of Adelaide | Australia | Master of Biomedical |
| Ho Chi Minh City University of Technology | Vietnam | Bachelor of Biotechnology |
| Year | Citation |
|---|---|
| 2024 | Yeo, K., Li, R., Wu, F., Bouras, G., Mai, L. T. H., Smith, E., . . . Fenix, K. (2024). Identification of consensus head and neck cancer-associated microbiota signatures: a systematic review and meta-analysis of 16S rRNA and The Cancer Microbiome Atlas datasets. Journal of Medical Microbiology, 73(2), 001799-1-001799-18. Scopus8 WoS6 Europe PMC7 |
| 2023 | GBD 2019 IMID Collaborators., Olagunju, A., & Gill, T. (2023). Global, regional, and national incidence of six major immune-mediated inflammatory diseases: findings from the global burden of disease study 2019.. EClinicalMedicine, 64(102193), 102193. Scopus114 WoS100 Europe PMC84 |
| 2022 | Mercieca-Bebber, R., Barnes, E. H., Wilson, K., Samoon, Z., Walpole, E., Mai, T., . . . Barbour, A. P. (2022). Patient-reported outcome (PRO) results from the AGITG DOCTOR trial: a randomised phase 2 trial of tailored neoadjuvant therapy for resectable oesophageal adenocarcinoma. BMC CANCER, 22(1), 11 pages. WoS2 |
| 2020 | Barbour, A. P., Walpole, E. T., Mai, G. T., Barnes, E. H., Watson, D., Ackland, S. P., . . . Smithers, B. M. (2020). Preoperative cisplatin, fluorouracil, and docetaxel with or without radiotherapy after poor early response to cisplatin and fluorouracil for resectable oesophageal adenocarcinoma (AGITG DOCTOR): results from a multicentre, randomised controlled phase II trial. ANNALS OF ONCOLOGY, 31(2), 236-245. WoS48 |
| Year | Citation |
|---|---|
| 2026 | Mai, L., Bouras, G., Yeo, K., Barry, E., Kulathunga, B., Hodge, J. -C., . . . Fenix, K. (2026). Genomic Signatures and Functional Pathways Underlying 5-Fluorouracil Resistance in Head and Neck Cancer associated Streptococci. DOI |
| 2026 | Mai, L., Bouras, G., Yeo, K., Hodge, J. -C., Barry, E., Krishnan, S., . . . Fenix, K. (2026). The Genomic Landscape of Head and Neck Cancer-associated Streptococci. DOI |